<DOC>
	<DOCNO>NCT03045068</DOCNO>
	<brief_summary>Hypothesis : Dilutional thrombocytopenia cardiopulmonary bypass ( CPB ) universal administration donor apheresis platelet prior termination bypass assist early correction coagulopathy , early hemostasis lesser donor exposure blood product cardiac surgery . Background : What Problem ? - Bleeding , Transfusion Outcomes 1 . Excessive bleeding neonatal cardiac surgery independently associate increased adverse event , morbidity mortality.1,2 Bleeding neonatal open-heart surgery multiple etiology immaturity building block coagulation , effect deep hypothermia , long CPB time , alter flow state dilutional state induce CPB lead low platelet count , low platelet function , low fibrinogen level , alter fibrinogen polymerization , complement activation , etc.2,3 The strong predictor transfusion cardiopulmonary bypass child deem CPB circuit volume effect hemodilution.4 2 . The dilutional coagulopathy neonatal CPB require intense damage control resuscitation massive transfusion platelet , pack red blood cell ( PRBC ) , cryoprecipitate , fresh frozen plasma ( FFP ) supplemental factor concentrate . In previous study institution ( IRB # HSC-MS-13-0647 ) , show neonate undergo open-heart surgery significant drop platelet count bypass ( 71 % change , baseline= 268 ± 90 , Post CPB= 76 ± 27 , 109/L ) . Associated drop , average intraoperative transfusion load neonates undergoing cardiac surgery CPB institution constitute PRBC= 63± 43 ml/kg , FFP=51± 21 ml/kg , cryoprecipitate =12+6 ml/kg , platelet = 28 +16 ml/kg cell-saver =27± 10 ml/kg . In addition 72 % patient expose 3-factor prothrombin complex concentrate ( Bebulin® ) . Although `` throw kitchen sink '' approach effective achieve hemostasis , come significant effect post CPB hemodynamics , constantly change hematocrit , variable blood volume inability achieve steady state inotropic state affect cardiac output , oxygen delivery add pulmonary hypertension . Overall , high platelet count time wean cardiopulmonary bypass distinct advantage reduce transfusion improve outcome .</brief_summary>
	<brief_title>Platelet Transfusion During Neonatal Open Heart Surgery</brief_title>
	<detailed_description>What institution ? The vast majority center include continue utilize regimen neonatal CPB prime constitutes PRBCs ( 20-30 ml/kg ) add achieve hematocrit &gt; 25 CPB FFP ( 20-30 ml/kg ) assist lower antithrombin level , improve heparin efficiency improve suppression thrombin generation CPB . Platelets add CPB prime institution . This regimen avoid donor apheresis platelet transfusion early CPB know effect CPB native platelet result decrease count hemodilution mechanical damage . Donor apheresis platelet administer initial constituent CPB prime also carry risk platelet activation hypothermia CPB potential activation coagulation cascade . Fresh whole blood also use secondary difficulty logistics pertain availability fresh whole blood make approach unattractive . What advantage add platelet apheresis prior separation CPB ? We know native platelet significantly reduce count function increase duration CPB function diminishes independently platelet count hypothermia.11 The advantage add donor apheresis platelet prior separate CPB donor platelet n't get spalliated deformed roller pump long duration , subject intense cool rewarming process spar early reperfusion injury/inflammation . Furthermore , addition 10 ml/kg platelet would raise platelet count least 50 % base previous study institution ( IRB # HSC-MS-13-0647 ; post-CPB platelet transfusion 28 ± 16 ml/kg result elevation platelet count 76 ± 27 223 ± 60 ( 109/L ) . Effect modify ultrafiltration ( MUF ) : MUF routinely perform immediately termination CPB prior protamine administration . During stage , successful wean CPB , 10-15 % cardiac output arterial cannula along residual volume venous reservoir CPB pump pump hemofilter place vacuum allow rapid hemofiltration effluent return via single atrial venous cannula patient . This 15-minute rapid hemofiltration allow removal excess water , improvement hematocrit improve oxygen delivery , faster achievement steady state inotrope level improve hemodynamics removal inflammatory mediators.12-14 While MUF improve hematocrit , increase platelet count significantly , MUF effect native platelet function.3 The big advantage transfusion apheresis platelet prior termination bypass versus standard practice transfusion protamine transfuse fluid load 10-15 ml/kg platelet volume would dilute red cell fraction ( hematocrit ) impact oxygen delivery pulmonary dysfunction would take full benefit modify ultrafiltration excess fluid removal even prior protamine administration overall improved hemodynamics . Institutional Blood transfusion Management Neonatal CPB For CPB prime : PRBCs ( 50ml/kg ) add allow hematocrit &gt; 30 estimate blood volume . FFP add pump prime patient weigh less 5 kilogram demonstrate heparin resistance initial heparin dose response assay . Heparin add CPB prime . Other constituent CPB prime epsilon aminocaproic acid ( 50 mg/kg ) , cefazolin ( 30 mg/kg ) methylprednisolone . Post CPB : Current practice neonate administer combination cryoprecipitate , platelet PRBC 1:1:1 ratio till hemostasis achieve . 3PCC factor administration base diffuse clinical bleed suggestive coagulopathy persist despite one round cryoprecipitate platelet transfusion . Study Method : Prospective Randomized trial neonate compare platelet apheresis transfusion prior termination CPB versus standard transfusion platelet apheresis modify ultrafiltration protamine administration . Primary outcome secondary outcome detail . Study Group Platelet Transfusion Management 1 . Pre-Termination CPB- Platelet Transfusion 10ml/kg administer patient via central venous access patient rewarmed 35*C , ( Sano BT shunt clip still child SV physiology ) 2 . Post CPB- Platelet transfusion 10ml/kg via central venous line continue rate 100 ml/hour till completion . FFP Cryoprecipitate : 1 . 1 unit cryoprecipitate administer MUF MUF need 2 . FFP transfusion 10ml/kg MUF MUF need PRBC cell saver Transfusion : 1 . Transfuse target Hematocrit &gt; 40 neonate SV physiology ; Transfuse Hematocrit &gt; 33 2-Ventricle physiology 3- Factor Concentrate ( Bebulin ) : 1 . Based clinical bleeding achievement hemostasis Control Group Platelet Transfusion Management 1 . Pre-Termination CPB- No intervention 2 . Post CPB- Platelet transfusion 20ml/kg via central venous line continue rate 100 ml/hour till completion . 1 . Initial transfusion occur proximal hemofilter MUF circuit long MUF last 2 . Subsequent platelet transfusion continue till completion via central venous access patient FFP Cryoprecipitate : 1 . 1 unit cryoprecipitate administer MUF MUF need 2 . FFP transfusion 10ml/kg MUF MUF need PRBC cell saver Transfusion : 1 . Transfuse target Hematocrit &gt; 40 neonate SV physiology ; Transfuse Hematocrit &gt; 33 2-Ventricle physiology 3 Factor Concentrate ( Bebulin ) : 1 . Based clinical bleeding achievement hemostasis Objectives ) Volume Blood Transfusion ( PRBC , FFP , Cryo , Platelets ) Number Donor Exposures ( PRBC , FFP , Cryo , Platelets ) termination CPB first 24 hour post op b ) Number exposures 4-PCC Factor 7 c ) Time termination CPB Chest Approximation 1 . Chest tube output first 24 hour 2 . Inotropic support time chest approximation 24 hour postop 3 . Length mechanical ventilation 4 . 30 day mortality 5 . Mediastinal exploration 6 . Delayed sternal closure 7 . Perioperative cardiac arrest first 72 hour 8 . Arrhythmia Sample size- Based pilot data collect standard procedure group , mean standard deviation ( SD ) total blood product intake first 24 hour 125.3+/- 71.1 ( ml/kg ) . To detect 1*SD unit reduction total blood intake , need 17 patient per group 80 % power 0.05 significance level . To account 20 % drop rate , need 22 patient per group , i.e . 44 patient total . Inclusion Criteria- All neonates infant less 3 month age 4 kilogram undergo open heart surgery cardiopulmonary bypass . Exclusion Criteria-1 ) Redo open heart surgery 2 ) Bleeding Disorders - von Willebrand Disease , Hemophilia Screening Recruitment : The list newborn operate obtained daily operating room log . Care4 record OR Tracking use screen patient Initials Patients , Date Brith , Date Surgery MRN collect . The Research Team ( PI Co-PI ) make contact family member obtain surgical anesthesia consent . Data Collected ( routine Standard operating procedure data ) Patient Demographics : MRN , Gestational age , Age operation , weight birth , weight operation , primary Diagnosis , Other diagnosis , Operative Data : CPB time , Aortic Cross Clamp time , Deep Hypothermic Circulatory Arrest time , Antegrade Cerebral perfusion time , Case duration . Pump Prime Constituents : Inotrope score : chest approximation { dopamine + dobutamine + ( epinephrine*100 ) + ( milrinone*10 ) 15 Procedure perform . Complications All Laboratory value perform baseline 24 hour postoperative ) Baseline- CBC Platelets , Fibrinogen , TEG b ) Rewarming , prior termination core temperature 35*C- CBC platelet , Fibrinogen , TEG c ) Arrival PICU- CBC platelet , fibrinogen , TEG ) 24 hour post op- CBC platelet , fibrinogen , TEG All Blood product administer age blood product time administration ( &lt; 5 day , &gt; 5days ) Post operative Length Intubation STS reportable complication Mortality Cumulative fluid balance first 72 hour . Outcome Variables : ) Number Donor Exposures ( PRBC , FFP , Cryo , Platelets ) termination CPB first 24 hour post op e ) Number exposures 4-PCC Factor 7 f ) Time termination CPB Chest Approximation ) Chest tube output first 24 hour j ) Inotropic support time chest approximation 24 hour postop k ) Length mechanical ventilation l ) 30 day mortality ) Mediastinal exploration n ) Delayed sternal closure ) Perioperative cardiac arrest first 72 hour p ) Arrhythmia Study Risks : There perceivable risk exposure platelet since patient expose platelet transfusion protamine administration . Only time administration change study group . Informed Consent : A write informed consent obtain . If informed consent obtainable refuse , patient randomize control arm .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Arrhythmias , Cardiac</mesh_term>
	<criteria>All neonates infant less 3 month age 4 kilogram undergo open heart surgery cardiopulmonary bypass 1 . Redo open heart surgery 2 . Bleeding Disorders von Willebrand Disease , Hemophilia</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>3 Months</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>